scholarly journals Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma

Cell Cycle ◽  
2013 ◽  
Vol 12 (12) ◽  
pp. 1811-1812 ◽  
Author(s):  
Caroline Bret ◽  
Bernard Klein ◽  
Jérôme Moreaux
Keyword(s):  
Dna Repair ◽  
High Risk ◽  
B Cell ◽  
Therapeutic Target ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Repair Pathway ◽  
Large B Cell Lymphoma ◽  
Nucleotide Excision ◽  
Large B Cell

scholarly journals Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial

2020 ◽  
Vol 31 (9) ◽  
pp. 1251-1259 ◽  
Author(s):  
A.K. McMillan ◽  
E.H. Phillips ◽  
A.A. Kirkwood ◽  
S. Barrans ◽  
C. Burton ◽  
...  
Keyword(s):  
High Risk ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Phase 2 ◽  
Front Line ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma

2019 ◽  
Vol 18 (9) ◽  
pp. 1520-1532 ◽  
Author(s):  
Taylor Hashiguchi ◽  
Nur Bruss ◽  
Scott Best ◽  
Vi Lam ◽  
Olga Danilova ◽  
...  
Keyword(s):  
B Cell ◽  
Therapeutic Target ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Cyclin Dependent Kinase ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients

Haematologica ◽  
2020 ◽  
Vol 105 (11) ◽  
pp. 2667-2670 ◽  
Author(s):  
Marita Ziepert ◽  
Stefano Lazzi ◽  
Raffaella Santi ◽  
Federica Vergoni ◽  
Massimo Granai ◽  
...  
Keyword(s):  
High Risk ◽  
Protein Expression ◽  
B Cell ◽  
Cell Lymphoma ◽  
Risk Group ◽  
B Cell Lymphoma ◽  
High Risk Group ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document